Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
{{output}}
Background and objectives: Following the discovery of new drugs, physicians and pharmaceutical companies have become interested in examining patients' mortality and morbidity rates. In this respect, the effects of methotrexate (MTX)+etanercept/infliximab (ETA/... ...
